Online Event – Aired on March 14!
Presentation
Nanolive’s imaging platforms were developed from the ground up, incorporating unique patented components, and valuable contributions from our beta testers in industry. This video highlights the key features that set Nanolive’s holotomographic imaging apart in our mission to give researchers access to unique live cell data through AI-assisted analysis, to accelerate and de-risk the discovery and development of therapeutics.
This video is part of the miniseries Discover label-free imaging technology with Nanolive.
What is holotomography, how does it work and what benefits does this live-cell imaging approach bring to fundamental research and drug development? This miniseries dives into the technology behind Nanolive’s high-content live cell images and explains how holotomography is essential for providing deep phenotypic insights into cellular responses.
You may be interested in this series if you:
- Are working on preclinical drug development in the biopharmaceutical industry
- Are an academic research scientist
- Want to understand drug toxicity and safety without the bias of labels
- Have a curious mindset and want to learn more about imaging technologies
Read our latest news
Label-free assessment of immunotherapies for liquid tumors
Simplifying drug delivery assessment: Industry perspectives
